Stand Off Between Cytogen And CytoRad

Stand-off between Cytogen and CytoRad

Cytogen Corp. and its CytoRad Inc. R&D partnership are at loggerheads over the future of the R&D partnership and funding and development of OncoScint PR prostate imaging agent and OncoRad ovarian and prostate therapeutics.

CytoRad (CYTDZ) has rejected CYTO's proposal to

Read the full 451 word article

How to gain access

Continue reading with a
two-week free trial.